SPS
NARI

Susquehanna Portfolio Strategies’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,592
Closed -$1.4M – 984
2023
Q4 		$1.4M Buy
+21,592
New +$1.3M 0.02% 516

Other funds holding NARI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Susquehanna Portfolio Strategies's NARI Position: Q1 2024 in Review

Susquehanna Portfolio Strategies sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2024, closing a stake of 21,592 shares — an estimated $1.4M sold.

Susquehanna Portfolio Strategies first reported a position in NARI in Q4 2023 and held it in 1 quarter. The position peaked at $1.4M in Q4 2023. 231 funds tracked by Wall St. Rank hold NARI as of Q1 2024.

  • Susquehanna Portfolio Strategies reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 21,592 Inari Medical, Inc. Common Stock shares in Q1 2024, an estimated $1.4M.
  • Susquehanna Portfolio Strategies first reported a position in Inari Medical, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Susquehanna Portfolio Strategies's Inari Medical, Inc. Common Stock position peaked at $1.4M in Q4 2023.
  • 231 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2024, filed 7 May 2024.